2022-01-17 08:35:13
Stocks to watch: Q&M Dental, Aoxin Q&M, Yoma, Lian Beng, Neratel, Econ Healthcare
THE following companies saw new developments that may affect trading of their securities on Monday (Jan 17):
SGX Listed Stock
AOXIN Q & M DENTAL GRP LIMITED (SGX:1D4)
Aoxin Q & M (SGX:1D4) Latest News
2021-12-16 09:09:14
MOH grants Covid-19 testing services to Acumen, up to 100 sites islandwide
ACUMEN Diagnostics, which is 51:49 owned by Q&M Dental Group and Aoxin Q&M Dental Group, on Thursday (Dec 16) announced that it has been granted a licence by the Ministry of Health to provide swabbing and Covid-19 polymerase chain reaction (PCR) tests services.
2021-12-16 08:25:14
Q&M's Acumen Diagnostics granted MOH Covid-19 offsite PCR testing license
Acumen Diagnostics, a 51%-owned subsidiary of Q&M Dental Group and 49%-owned by Aoxin Q&M Dental Group, says it has been granted a license by the Ministry of Health (MOH) to provide offsite Covid-19 polymerase chain reaction (PCR) swab services and serology sample collection. Acumen Diagnost...
2021-12-07 08:24:20
Stocks to watch: Keppel Corp, Olam International, Maxi-Cash, Aoxin Q&M
THE following companies saw new developments that may affect trading of their securities on Tuesday (Dec 7):
2021-12-06 18:42:08
Aoxin Q&M reopens 4 shuttered Chinese dental centres after Covid-19 hits Liaoning
CATALIST-LISTED Aoxin Q & M Dental Group said on Monday (Dec 6) that it has reopened 4 of its dental centres in the Chinese province of Liaoning.
2021-12-03 09:03:41
Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant
Acumen Diagnostics, the 51%-owned subsidiary of Q&M Dental Group and 49%-owned by Aoxin Q&M Dental, says its proprietary, locally-manufactured polymerase chain reaction (PCR) test kits are able to detect Covid-19 positive cases with the Omicron variant. The kits are named Acu-Corona 2.0 and ...
2021-11-20 05:50:00
UOBKH initiates 'buy' on Aoxin Q&M with S$0.37 target price
AOXIN Q&M is expected to see a strong turnaround on its earnings after its recent acquisition of Acumen Diagnostics and improved performance from its China dental business, said UOB Kay Hian (UOBKH).
2021-11-19 10:48:24
UOB Kay Hian initiates coverage on Aoxin with "buy" call and 37 cents target price
UOB Kay Hian analyst John Cheong has initiated coverage on Aoxin Q & M Dental Group with a “buy” call and 37 cents target price, on bullish expectations that the company will see a turnaround led by strong contributions from its newly-acquired business in China. Cheong expects Aoxin, which r...
2021-11-19 12:28:08
Brokers' take: UOBKH initiates 'buy' on Aoxin Q&M with S$0.37 target price
AOXIN Q&M (1D4) is expected to see a strong turnaround on its earnings after its recent acquisition of Acumen Diagnostics and improved performance from its China dental business, according to UOB Kay Hian (UOBKH).
2021-10-06 05:50:00
Aoxin Q&M's acquisition will raise its exposure to PCR testing demand: deputy CEO
AOXIN Q&M Dental Group is boosting its exposure in the Covid-19 testing space. The Catalist-listed company expects its acquisition of a stake in medical technology company Acumen Diagnostics to improve its top and bottom lines.
Your Say
Stock / REIT Search
Advertisement